Desmopressin Acetate NDC 10702-170

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-170Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0170Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10702-170-01	10702017001	100 TABLET in 1 BOTTLE (10702-170-01)Marketed from Jan 28, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desmopressin Acetate
Generic name (nonproprietary): desmopressin acetate
Active ingredients: Desmopressin acetate — .2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: KVK-TECH, INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210371
Marketing start: Jan 28, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Increased Coagulation Factor VIII Activity (Physiologic effect)Increased Coagulation Factor VIII Concentration (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 10702-170_11e764a6-0d02-ec11-e063-6394a90a195eSPL ID 11e764a6-0d02-ec11-e063-6394a90a195eSPL set ID 9fba5e90-f541-4588-a5e9-b56198f17e87RxCUI 833008, 849515UNII XB13HYU18U
Pharmacologic class: Factor VIII Activator; Vasopressin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410702017001 followed by a unit qualifier and the quantity

Package 10702-0170-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 21, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Central Diabetes Insipidus Desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. Desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. Patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. Continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. Primary Nocturnal Enuresis Desmopre…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210371

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210371
Product	Strength	Form · route	Labeler	Product NDC
Desmopressin Acetate	Desmopressin acetate .1 mg/1	TabletOral	KVK-TECH, INC.	10702-169
Desmopressin Acetate	Desmopressin acetate .2 mg/1	TabletOral	Northwind Health Company, LLC	51655-461